"Although there is no way to quantify the daily suffering and long-term harm caused by Endo, the Endo settlement funds will provide financial resources necessary to combat the far-reaching effects of illegal opioid marketing," said Kelly Levy, Acting Director of the Office of the New Jersey Coordinator for Addiction Responses and Enforcement Strategies ( NJ CARES ). "We are committed to using these funds to continue our all-hands on deck approach to lessening the impact of the opioid crisis has on the lives of New Jersey residents on a daily basis."